Cryotherapy for Ablation of Cancer

A cryotherapy system provides a minimally invasive treatment option for the ablation of cancerous kidney masses and prostate cancer. The system has been cleared by the US Food and Drug Administration (FDA) for both applications.

The system employs ultra-thin proprietary CryoNeedles, which are guided by ultrasound or magnetic resonance imaging (MRI) to the targeted region, enabling the doctor to visualize the freeze-zone in real-time. Called SeedNet Gold, the system is the product of Galil Medical Ltd. The company develops and markets systems incorporating advanced hypercooling technology that allows for extremely fast, high-resolution, controlled destruction of cancerous tissue.

"SeedNet Gold is fast becoming the gold standard for urologists doing cryoablative procedures for prostate and renal cancers,” said James McGlone, president and CEO of Gailil Medical. "Patients, when given a choice, are choosing minimally invasive procedures.”




Related Links:
Galil Medical